Tempur Sealy International, Inc. — Cyborg Score 8/10

Strong
Premium and mid-market mattresses

Strategic Profile

The company's competitive advantage lies in strong brand equity, vertical integration through Mattress Firm ownership, and successful execution of synergies. With record EBITDA of $419 million in Q3 2025 and projected $1.3 billion in Adjusted EBITDA for full-year 2025, Tempur Sealy is leveraging scale and distribution to drive margin expansion and capture retail demand across both premium and value segments.

Cyborg Score Rationale

Tempur Sealy demonstrates strong execution in a mature but resilient consumer market. Record Q3 2025 results show 52% EBITDA growth, strategic vertical integration is delivering measurable synergies, and the company maintains pricing power in premium mattress categories. Key risks include retail cyclicality and integration execution.

Top Insights

  • Q3 2025 delivered record net sales of $2.1B (63% growth YoY) and Adjusted EBITDA of $419M (52% growth), demonstrating successful Mattress Firm integration and synergy capture
  • Vertical integration through Mattress Firm acquisition is delivering $60M in projected EBITDA sales synergies for full-year 2025, with additional store upgrade investments ($25M) supporting long-term retail positioning
  • Raised full-year 2025 guidance to $2.60-$2.75 Adjusted EPS and ~$1.3B Adjusted EBITDA midpoint, signaling confidence in momentum and synergy realization
  • New Sealy Posturepedic product line launch supports brand differentiation and addresses value-conscious consumer segments, expanding addressable market beyond premium Tempur-Pedic positioning

Named Competitors

  • Sleep Number — Premium adjustable air mattress technology
  • Purple — Gel-infused memory foam mattresses with innovation focus
  • Serta Simmons — Multi-brand traditional mattress platform
  • Casper — Direct-to-consumer foam mattress pioneer

Recent Developments

  • (Q3 2025) Record quarterly results with $2.1B net sales and $419M Adjusted EBITDA; Mattress Firm vertical integration showing strong synergy realization
  • (Q4 2025) Updated full-year guidance raised to $2.60-$2.75 Adjusted EPS and ~$1.3B Adjusted EBITDA midpoint
  • (2025) Sealy Posturepedic product line introduced to compete in mid-market segment and complement Tempur-Pedic premium positioning
  • (June 2026) Market capitalization of $15.8B as of June 20, 2026, reflecting investor confidence in integration execution

Open the full interactive Tempur Sealy International, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →